Your practice can help cats get back where they belong
Control Feline Osteoarthritis (OA) Pain
Solensia is the feline OA pain control therapy designed with the practice, the client, and the cat in mind.
OA IN CATS
The Prevalence of Feline OA
The Prevalence of Feline Osteoarthritis
Feline OA is highly prevalent, but it can be difficult to diagnose cats when they don’t visit.
Nearly 40% of all cats have clinical signs of OA1
% Feline Patient Visits by Age2
60% of cats ≥6 years of age are affected by OA3
90% of cats >12 years of age are affected by OA4
How many cats in your practice are affected by OA?
Screening for OA pain at wellness exams can reveal the number.
Ensure Your Feline OA Diagnoses Add Up
OA is brought up in only 20% of cat visits.5
The Cat OA Pain Checklist is proven to support diagnosis
When used, diagnosis rates increased significantly from 3% to 39%6
Be sure to make EVERY cat visit count.
Access the checklist and other tools that can support diagnosis.
MULTIMODAL THERAPY
Analgesia is Foundational to a Multimodal OA Treatment Approach
Pain is the primary experience and treatable sign of OA
It is a multidimensional and uniquely individual experience
Pain becomes its own disease state when left untreated
Goals for Managing Feline OA
- Controlling pain
- Maintaining mobility
- Slowing the progression of the disease
But multimodal treatment can come with an unintended cost:
TREATMENT FOR OA
Treat Cats Monthly With Solensia
Providing early, effective treatment designed for long-term OA pain management is the goal. Solensia helps keep OA pain from disrupting the unique bond cats share with their humans.
How Solensia treats cats:
A monoclonal antibody that is metabolized the same as all proteins
Targets Nerve Growth Factor, a key driver in OA pain progression
Targets Nerve Growth Factor, a key driver in OA pain progression
Administered in the veterinary clinic as a monthly injection
Ask your sales rep to learn more about Solensia.
Or order it for your practice now.
Insert text here...
View tips for examining cats for OA
Find additional resources for OA pain
Get an OA checklist for your clients
References
- Enomoto M, Mantyh PW, Murrell J, Innes JF, Lascelles BDX. Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats. Vet Rec. 2019;184(1):23.
- Zoetis Market Research: Feline Visit Growth Age MAT. September 2022.
- Slingerland L, Hazewinkel H, Meij B, Picavet P, Voorhout G. Cross-sectional study of the prevalence and clinical features of osteoarthritis in 100 cats. Vet J. 2011;187:304-309.
- Hardie EM, Roe SC, Martin FR: Radiographic evidence of degenerative joint disease in geriatric cats: 100 cases (1994-1997). J Am Vet Med Assoc. 2002;220:628-632.
- Data on file: Kynetec: OA Landscape Chart Pull Study, May 2023.
- Gober M. Prospective: How do veterinarians diagnose feline OA?, 19SORPAS-02-01.
SLN-00004R5
IMPORTANT SAFETY INFORMATION:
See full Prescribing Information. For use in cats only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid self-injection. Hypersensitivity reactions, including anaphylaxis, could potentially occur with self-injection. Solensia should not be used in breeding cats or in pregnant or lactating queens. Solensia should not be administered to cats with known hypersensitivity to frunevetmab. The most common adverse events reported in a clinical study were vomiting and injection site pain.